Frank J. Mccaney Acquires 20,000 Shares of Mela Sciences Inc. (SSKN) Stock
Mela Sciences Inc. (NASDAQ:SSKN) CEO Frank J. Mccaney bought 20,000 shares of the business’s stock in a transaction that occurred on Monday, November 28th. The stock was acquired at an average cost of $0.51 per share, with a total value of $10,200.00. Following the completion of the acquisition, the chief executive officer now owns 8,865 shares of the company’s stock, valued at approximately $4,521.15. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
Mela Sciences Inc. (NASDAQ:SSKN) traded up 3.38% on Monday, hitting $0.52. 208,901 shares of the company were exchanged. The stock’s 50-day moving average price is $0.50 and its 200-day moving average price is $0.62. Mela Sciences Inc. has a 52-week low of $0.46 and a 52-week high of $1.53. The stock’s market capitalization is $5.55 million.
TRADEMARK VIOLATION WARNING: This piece of content was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece of content on another domain, it was stolen and republished in violation of U.S. & international trademark & copyright laws. The correct version of this piece of content can be read at https://www.thecerbatgem.com/2016/11/28/frank-j-mccaney-acquires-20000-shares-of-mela-sciences-inc-sskn-stock.html.
A hedge fund recently raised its stake in Mela Sciences stock. Sabby Management LLC increased its stake in Mela Sciences Inc. (NASDAQ:SSKN) by 78.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,020,524 shares of the medical device company’s stock after buying an additional 447,447 shares during the period. Sabby Management LLC owned approximately 9.64% of Mela Sciences worth $623,000 at the end of the most recent quarter. 24.49% of the stock is owned by institutional investors and hedge funds.
About Mela Sciences
STRATA Skin Sciences, Inc, formerly MELA Sciences, Inc, is a medical technology company. The Company is engaged in developing and commercializing products for the diagnosis and treatment of dermatological disorders. The Company has three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment and Dermatology Imaging.
Receive News & Stock Ratings for Mela Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mela Sciences Inc. and related stocks with our FREE daily email newsletter.